Search

Your search keyword '"Valentina Rosa Bertuzzo"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Valentina Rosa Bertuzzo" Remove constraint Author: "Valentina Rosa Bertuzzo"
55 results on '"Valentina Rosa Bertuzzo"'

Search Results

1. Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up

2. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial

3. Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant

4. Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial

5. Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria

6. The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation:An Italian Cohort Study

8. PORTO-CAVAL SHUNT IN SPLIT LIVER TRASPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT?

9. DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC

10. LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS?

11. RANDOMIZED TRIAL ON HYPOTHERMIC OXYGENATED PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION FROM EXTENDED CRITERIA DONORS: INTERIM ANALYSIS

12. Pre-transplant Psoas Muscle Density as a Ready-to-Use and Low-cost Predictor of Patient Survival After Liver Transplant

13. Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial

14. Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation

15. MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI

16. RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA

17. Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial

18. Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions

19. Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study

20. Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas

21. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function

22. HCV and Kidney Transplantation: Pushing the Limits for Living Donation. Case Report and Mini Review

23. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial

24. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study

25. Antifungal prophylaxis in liver transplant recipients: one size does not fit all

26. Combined effect of recipient age and graft fibrosis on liver transplantation outcomes: Tailoring the best donor/recipient match in the extended criteria age

27. Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection

28. High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation

29. Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus

30. Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era

31. Impact of preoperative infection on outcome after liver transplantation

32. Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases”

33. Simultaneous resection for synchronous colorectal liver metastases: are major hepatectomy and/or rectal surgery real contraindications?

34. Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature

35. Reply

37. Long-term antiviral treatment for recurrent hepatitis C after liver transplantation

38. Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?

39. Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers

40. Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy?

41. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial

42. Combined abdominal transplantation: Liver-kidney

43. Retransplantation (Causes, Outcome)

44. The Impact of Conversion from Prograf to Generic Tacrolimus in Liver Transplant Recipients With Stable Graft Function

45. Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis

46. Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature

47. Peritoneal seeding from appendiceal carcinoma: A case report and review of the literature

48. Liver transplantations with donors aged 60 years and above: the low liver damage strategy

49. Survival Benefit After Liver Transplantation: A Single European Center Experience

50. 523 PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION

Catalog

Books, media, physical & digital resources